Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Gentry

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 15, 2000
Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokineticsH J Clewell, J M Gearhart, P R Gentry, et al.
Inhalation Toxicology|September 9, 2020
Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053)H J Clewell, J L Campbell, C Van Landingham, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2014
A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloropreneB C Allen, C Van Landingham, Y Yang, et al.
Toxicology and Applied Pharmacology|August 9, 2019
Assessing children's exposure to manganese in drinking water using a PBPK modelM Yoon, C Ring, C B Van Landingham, et al.
Inhalation Toxicology|April 11, 2001
A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposureC B Frederick, P R Gentry, M L Bush, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 15, 2000
Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokineticsH J Clewell, J M Gearhart, P R Gentry, et al.
Inhalation Toxicology|September 9, 2020
Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053)H J Clewell, J L Campbell, C Van Landingham, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2014
A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloropreneB C Allen, C Van Landingham, Y Yang, et al.
Toxicology and Applied Pharmacology|August 9, 2019
Assessing children's exposure to manganese in drinking water using a PBPK modelM Yoon, C Ring, C B Van Landingham, et al.
Inhalation Toxicology|April 11, 2001
A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposureC B Frederick, P R Gentry, M L Bush, et al.
Pageof 2